Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Free Subscription

Articles published in PLoS Med

Retrieve available abstracts of 14 articles:
HTML format
Text format

Single Articles

    August 2019
  1. OKALA SG, Darboe MK, Sosseh F, Sonko B, et al
    Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia.
    PLoS Med. 2019;16:e1002854.
    PubMed     Text format     Abstract available

    July 2019
  2. CHOI YH, Andrews N, Miller E
    Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study.
    PLoS Med. 2019;16:e1002845.
    PubMed     Text format     Abstract available

  3. BAKER MA, Baer B, Kulldorff M, Zichittella L, et al
    Kawasaki disease and 13-valent pneumococcal conjugate vaccination among young children: A self-controlled risk interval and cohort study with null results.
    PLoS Med. 2019;16:e1002844.
    PubMed     Text format     Abstract available

    April 2019
  4. VEKEMANS J, O'Brien KL, Farrar J
    Tuberculosis vaccines: Rising opportunities.
    PLoS Med. 2019;16:e1002791.
    PubMed     Text format     Abstract available

    March 2019
    Measles vaccination: A matter of confidence and commitment.
    PLoS Med. 2019;16:e1002770.
    PubMed     Text format     Abstract available

    August 2018
  6. KAHN R, Rid A, Smith PG, Eyal N, et al
    Choices in vaccine trial design in epidemics of emerging infections.
    PLoS Med. 2018;15:e1002632.
    PubMed     Text format     Abstract available

    March 2018
  7. POWELL-JACKSON T, Fabbri C, Dutt V, Tougher S, et al
    Effect and cost-effectiveness of educating mothers about childhood DPT vaccination on immunisation uptake, knowledge, and perceptions in Uttar Pradesh, India: A randomised controlled trial.
    PLoS Med. 2018;15:e1002519.
    PubMed     Text format     Abstract available

    February 2018
  8. FINGER F, Bertuzzo E, Luquero FJ, Naibei N, et al
    The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study.
    PLoS Med. 2018;15:e1002509.
    PubMed     Text format     Abstract available

    Preventing cholera outbreaks through early targeted interventions.
    PLoS Med. 2018;15:e1002510.
    PubMed     Text format     Abstract available

    January 2018
  10. YAESOUBI R, Trotter C, Colijn C, Yaesoubi M, et al
    The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study.
    PLoS Med. 2018;15:e1002495.
    PubMed     Text format     Abstract available

  11. SRINIVASAN P, Wu X, Basu M, Rossi C, et al
    PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease.
    PLoS Med. 2018;15:e1002497.
    PubMed     Text format     Abstract available

    November 2017

  12. malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication.
    PLoS Med. 2017;14:e1002455.
    PubMed     Text format     Abstract available

    October 2017
  13. AGNANDJI ST, Fernandes JF, Bache EB, Obiang Mba RM, et al
    Safety and immunogenicity of rVSVDeltaG-ZEBOV-GP Ebola vaccine in adults and children in Lambarene, Gabon: A phase I randomised trial.
    PLoS Med. 2017;14:e1002402.
    PubMed     Text format     Abstract available

    September 2017
  14. CANFELL K, Caruana M, Gebski V, Darlington-Brown J, et al
    Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    PLoS Med. 2017;14:e1002388.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.